Table 1.

Chemotherapy medicine availability in South Africa per healthcare sector.

Healthcare Sector	Guideline chemotherapy selection	Medicines available
Public	Department of Health Master Procurement Catalogue (EML and STG)	5-FU (+LV), Capecitabine, Oxaliplatin, aIrinotecan
Private	Various medical aid scheme formularies for the South African Health Products Regulatory Authority (previously Medicines Control Council) approved medicines	5-FU (+LV), Capecitabine, Oxaliplatin, Irinotecan, Bevacizumab, Cetuximab, bPanitumumab, cAflibercept, bRegorafenib

^a Subsequent to this study has been approved for use in the public sector. Medicines underlined are available in both healthcare sectors.

^bSubsequent to this study Panitumumab and Regorafenib have been approved for use by SAHPRA - South African Health Products Regulatory Authority – but was previously available through a Section 21named patient use application.

^cNot yet registered for use in South Africa but is available through Section 21 named patient application.